Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Bossert

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|December 17, 2013
The yule approximation for the site frequency spectrum after a selective sweepSebastian Bossert, Peter Pfaffelhuber
Pharmaceutical Statistics|January 21, 2022
Bayesian MCPModFrank Fleischer, Sebastian Bossert, Qiqi Deng, et al.
ERJ Open Research|October 27, 2022
Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosisToby M Maher, Christina Schlecker, Doreen Luedtke, et al.
Advances in Therapy|July 22, 2024
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I StudyGuoying Cao, Haijing Yang, Jingjing Wang, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2021
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasisPatrick Baum, Sudha Visvanathan, Sandra Garcet, et al.
Frontiers in Medicine|November 10, 2022
Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseasesMarilisa Konietzke, Simon M F Triphan, Monika Eichinger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|December 17, 2013
The yule approximation for the site frequency spectrum after a selective sweepSebastian Bossert, Peter Pfaffelhuber
Pharmaceutical Statistics|January 21, 2022
Bayesian MCPModFrank Fleischer, Sebastian Bossert, Qiqi Deng, et al.
ERJ Open Research|October 27, 2022
Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosisToby M Maher, Christina Schlecker, Doreen Luedtke, et al.
Advances in Therapy|July 22, 2024
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I StudyGuoying Cao, Haijing Yang, Jingjing Wang, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2021
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasisPatrick Baum, Sudha Visvanathan, Sandra Garcet, et al.
Frontiers in Medicine|November 10, 2022
Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseasesMarilisa Konietzke, Simon M F Triphan, Monika Eichinger, et al.
Pageof 1